For instance, copy number amplification of MAPKAPK2 is believed to elevate the prognostic risk of lung cancer patients, whereas copy number of MAPK kinase 3 is thought to increase breast cancer risk (Kuiper et al., 2010; Liu et al., 2012; MacNeil et al., 2014). This evidence concerns the gene MAPKAPK2 and lung carcinoma.